A detailed history of Foundations Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 16,656 shares of AMGN stock, worth $4.39 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
16,656
Previous 14,940 11.49%
Holding current value
$4.39 Million
Previous $4.67 Million 14.95%
% of portfolio
0.12%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $530,896 - $578,944
1,716 Added 11.49%
16,656 $5.37 Million
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $560,708 - $681,407
2,134 Added 16.66%
14,940 $4.67 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $255,964 - $308,981
-952 Reduced 6.92%
12,806 $3.64 Million
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $250,330 - $282,402
-979 Reduced 6.64%
13,758 $3.96 Million
Q3 2023

Oct 05, 2023

BUY
$218.65 - $271.46 $67,125 - $83,338
307 Added 2.13%
14,737 $3.96 Million
Q2 2023

Jul 19, 2023

SELL
$214.27 - $253.37 $452,752 - $535,370
-2,113 Reduced 12.77%
14,430 $3.2 Million
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $1.21 Million - $1.48 Million
5,363 Added 47.97%
16,543 $4 Million
Q4 2022

Jan 11, 2023

BUY
$229.03 - $291.01 $1.47 Million - $1.86 Million
6,398 Added 133.79%
11,180 $0
Q3 2022

Oct 19, 2022

BUY
$224.46 - $253.15 $551,498 - $621,989
2,457 Added 105.68%
4,782 $1.08 Million
Q2 2022

Jul 08, 2022

BUY
$230.71 - $256.74 $98,974 - $110,141
429 Added 22.63%
2,325 $570,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $36,179 - $40,024
165 Added 9.53%
1,896 $482,000
Q4 2021

Jan 21, 2022

BUY
$198.88 - $227.6 $344,261 - $393,975
1,731 New
1,731 $401,000
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $180,005 - $210,124
-1,009 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $186,957 - $210,770
1,009 New
1,009 $209,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Foundations Investment Advisors, LLC Portfolio

Follow Foundations Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundations Investment Advisors, LLC with notifications on news.